Trials / Completed
CompletedNCT03338153
Evaluation of Long-term Coronary Stenting Outcomes in Diabetic Patients With or Without Optimal Glycemic Control
Evaluation of Long-term Coronary Stenting Outcomes in Diabetic Patients With or Without Optimal Glycemic Control Referring to Tehran Heart Center Since June 2007 to June 2009
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 1,353 (actual)
- Sponsor
- Tehran Heart Center · Academic / Other
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
the purpose of this study is to determine whether appropriate control of diabetes around the PCI time is related with MACE and outcome of diabetic patients.
Detailed description
Despite recent advances in coronary revascularization, cardiovascular disease accounts for about 75% of all hospital admissions in diabetic patients.although the introduction of drug-eluting stents has reduced the rates of restenosis after PCI, diabetic patients undergoing PCI will have poorer clinical outcomes.In this study, we sought to investigate whether a pre and post procedural glycemic control in diabetic patients,as reflected by HgbA1C prior,1 and 6 months after elective PCI,was related to major advance cardiac events (MACE) during 3 year follow up.
Conditions
Timeline
- Start date
- 2007-10-01
- Primary completion
- 2009-12-01
- Completion
- 2013-03-01
- First posted
- 2017-11-09
- Last updated
- 2017-11-09
Locations
1 site across 1 country: Iran
Source: ClinicalTrials.gov record NCT03338153. Inclusion in this directory is not an endorsement.